A股異動丨提示風險,杭齒前進一度跌停,上一交易日曾創新高
上週五創歷史新高的杭齒前進(601177.SH)早盤曾封跌停板,現報21.9元跌幅收窄至8.6%,總市值88.7億元。消息上,公司上週五晚間發佈股票交易風險提示,自2025年2月12日以來,公司股票收盤價在連續17個交易日內已出現11個升停,累計升幅達147.14%,股票價格短期內實際波動幅度較大。近一個月,公司股票累計升幅為160.83%。公司股票短期升幅嚴重高於同期行業指數,存在市場情緒過熱的情形,可能存在非理性炒作。截至2025年3月7日,公司股票收盤價為23.97元/股,處於歷史高位,存在短期大幅下跌的風險。(格隆匯)

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.